Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576388 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Superior Ophthalmic Vein Thrombosis Associated With Acute Suppurative Parotitis and Masticator Space Cellulitis: A Case Report and Review of the Literature.
Cureus
November 2024
Pulmonology/Critical Care Medicine, Summa Health, Akron, USA.
Superior ophthalmic vein thrombosis (SOVT) is a rare phenomenon caused by both septic and aseptic etiologies. Individuals suffering from SOVT commonly present with ophthalmoplegia, proptosis, chemosis, and impaired vision. The superior ophthalmic vein is a valveless vein that drains into the cavernous sinus; for this reason, SOVT can present with dire complications such as cavernous sinus thrombosis in addition to debilitating permanent ophthalmoplegia and permanent vision loss if left untreated.
View Article and Find Full Text PDFBilateral Orbital Cellulitis Causing Septic Pulmonary Embolism and Subsequent Bilateral Pneumothorax: A Rare Case Report.
Int Med Case Rep J
November 2024
Radiology Department, Mogadishu Somali Turkey, Recep Tayyip Erdogan Training and Research Hospital, Mogadish, Somalia.
Introduction: Septic pulmonary embolism is a serious and rare complication of orbital cellulitis. Orbital infection usually arises from adjacent soft tissue or hematogenous infections.
Case: A 2-year-old girl presented with high-grade fever, cough, and bilateral eyelid swelling for 5 days preceded by edema and a perinasal facial skin furuncle.
Cavernous Sinus Thrombosis Associated With Contralateral Pansinusitis: A Case Report.
Cureus
October 2024
Otolaryngology, Betsi Cadwaladr University Health Board, Wrexham, GBR.
A healthy woman in her 60s presented acutely with right-sided periorbital edema, erythema, neck pain, and fever. Initial examination and investigations suggested right-sided orbital cellulitis with contralateral pansinusitis. Despite treatment with IV antibiotics, her symptoms worsened, and inflammatory markers continued to rise.
View Article and Find Full Text PDFAnticoagulation in the management of septic cavernous sinus thrombosis secondary to rhino-orbito-cerebral mucormycosis: A retrospective real-world experience.
Curr J Neurol
January 2024
Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- COVID-19 has been linked to an increase in mucormycosis and subsequently septic cavernous sinus thrombosis, prompting a study on the effects of anticoagulation (AC) in patients with COVID-related complications.
- In this retrospective study involving 29 patients, researchers compared health outcomes, including mortality and neurological sequelae, between those who received AC and those who did not.
- The findings indicated no significant differences in recovery or mortality rates between AC receivers and non-receivers, but due to the small sample size, the results remain inconclusive regarding the effectiveness of AC in this context.*
Persistent Fever in Bilateral Septic Cavernous Sinus Thrombosis: A Case Report.
Cureus
September 2024
Department of Internal Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, USA.
Septic cavernous sinus thrombosis (SCST) is a rare and life-threatening condition characterized by thrombus formation within the cavernous sinus, typically resulting from the spread of infection from facial, paranasal sinus, or dental origins. We report the case of a middle-aged man with a history of methicillin-resistant Staphylococcus aureus (MRSA) skin infections who presented with severe neck pain, fever, and bilateral eye swelling. The patient was bacteremic with MRSA and found on imaging to have thickening of extraocular muscles and air-fluid levels present within the sphenoid sinuses.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!